Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera immune cell dynamics study in multiple sclerosis
NL-OMON42490Phase 4Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dimethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Quantification of target lymphocyte subset numbers over time, Production and disappearance rates of target lymphocyte subsets and 6 more. Started Aug 2016; status: active, not recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON42490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42490.